Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap in January 2024

World Top 100 Healthcare Companies List by Market Cap in January 2024, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Healthcare Companies in 2024
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2024, World Top Healthcare Companies by Market Cap in 2024.
  1. Hanmi Pharm

    World Rank (Jan-05-2024)
    3,913
    Market Cap (Jan-05-2024)
    3.470 Billion USD
    World Rank (Jul-30-2023)
    4,698
    Market Cap (Jul-30-2023)
    2.685 Billion USD
    World Rank (Dec-25-2022)
    4,231
    Market Cap (Dec-25-2022)
    2.866 Billion USD
    World Rank (Jan-07-2022)
    5,222
    Market Cap (Jan-07-2022)
    2.70 Billion USD
    Annual Revenue in USD
    900 Million USD
    Annual Net Income in USD
    50 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Pharmaceutical Company with headquarters is in South Korea.
  2. Xenon Pharmaceuticals

    World Rank (Jan-05-2024)
    3,922
    Market Cap (Jan-05-2024)
    3.464 Billion USD
    World Rank (Jul-30-2023)
    5,199
    Market Cap (Jul-30-2023)
    2.331 Billion USD
    World Rank (Dec-25-2022)
    4,829
    Market Cap (Dec-25-2022)
    2.382 Billion USD
    World Rank (Jan-07-2022)
    7,271
    Market Cap (Jan-07-2022)
    1.57 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Net Income in USD
    -28 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Xenon Pharmaceuticals is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The headquarters is in Canada.
  3. Sime Darby Berhad

    World Rank (Jan-05-2024)
    3,960
    Market Cap (Jan-05-2024)
    3.412 Billion USD
    World Rank (Jul-30-2023)
    4,140
    Market Cap (Jul-30-2023)
    3.218 Billion USD
    World Rank (Dec-25-2022)
    3,527
    Market Cap (Dec-25-2022)
    3.658 Billion USD
    World Rank (Jan-07-2022)
    3,994
    Market Cap (Jan-07-2022)
    3.88 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Net Income in USD
    0 Million USD
    Annual Results for Period Ending
    Jun-2021 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Manufacture industrial machinery, automobile parts, motors. It has also business in hospitals, retail, insurance. Headquarters is in Kuala Lumpur, Malaysia.

  4. GW Pharmaceuticals

    World Rank (Jan-05-2024)
    3,962
    World Rank (Jul-30-2023)
    3,962
    World Rank (Dec-25-2022)
    3,962
    World Rank (Jan-07-2022)
    3,962
    Annual Revenue in USD
    527 Million USD
    Annual Net Income in USD
    -58 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    GW Pharmaceuticals is a position in the development of plant derived cannabinoid therapeutics through it proven drug discovery and development processes intellectual property portfolio and regulatory and manufacturing expertise. The headquarters is in UK.

  5. MoonLake Immunotherapeutics

    World Rank (Jan-05-2024)
    3,968
    Market Cap (Jan-05-2024)
    3.404 Billion USD
    World Rank (Jul-30-2023)
    4,196
    Market Cap (Jul-30-2023)
    3.164 Billion USD
    World Rank (Dec-25-2022)
    14,035
    Market Cap (Dec-25-2022)
    0.390 Billion USD
    Headquarters Country
    Company Profile
    MOONLAKE IMMUNOTHERAPEUTICS is a clinical stage biopharmaceutical company with the novel investigational Nanobody for the treatment of inflammation to revolutionize outcomes for patients. The headquarters is in Switzerland.
  6. Biohaven Pharmaceutical Holding Company

    World Rank (Jan-05-2024)
    3,972
    Market Cap (Jan-05-2024)
    3.399 Billion USD
    World Rank (Jul-30-2023)
    7,470
    Market Cap (Jul-30-2023)
    1.300 Billion USD
    World Rank (Dec-25-2022)
    8,706
    Market Cap (Dec-25-2022)
    0.934 Billion USD
    World Rank (Jan-07-2022)
    2,147
    Market Cap (Jan-07-2022)
    8.44 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -567 Million USD
    Annual Net Income in USD
    -570 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Biohaven Pharmaceutical Holding Company is a Clinical Stage Biopharmaceutical company. It portfolio is comprised of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases including rare disorders. The company is rapidly progressing multiple compounds in clinical trials across three platforms they are calcitonin gene related peptide receptor antagonism, glutamate modulation and myeloperoxidase inhibition. The headquarters is in USA.

  7. Ajanta Pharma

    World Rank (Jan-05-2024)
    3,979
    Market Cap (Jan-05-2024)
    3.395 Billion USD
    World Rank (Jul-30-2023)
    4,990
    Market Cap (Jul-30-2023)
    2.469 Billion USD
    World Rank (Dec-25-2022)
    5,749
    Market Cap (Dec-25-2022)
    1.835 Billion USD
    World Rank (Jan-07-2022)
    5,263
    Market Cap (Jan-07-2022)
    2.67 Billion USD
    Annual Revenue in USD
    411 Million USD
    Annual Net Income in USD
    89 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. The company annual revenue is 28,896 million INR and annual net income is 6,538 million INR as on 2021. The headquarters is in India.
  8. Krystal Biotech

    World Rank (Jan-05-2024)
    3,986
    Market Cap (Jan-05-2024)
    3.388 Billion USD
    World Rank (Jul-30-2023)
    4,110
    Market Cap (Jul-30-2023)
    3.259 Billion USD
    World Rank (Dec-25-2022)
    5,498
    Market Cap (Dec-25-2022)
    1.973 Billion USD
    World Rank (Jan-07-2022)
    7,197
    Market Cap (Jan-07-2022)
    1.60 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -120 Million USD
    Annual Net Income in USD
    -139 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Krystal Biotech is a Clinical Stage Gene Therapy company. It initially developing topical and intradermal "off-the-shelf" novel therapies for rare and orphan dermatological indications and expanding the use of pioneering STAR-D technology to target and treat other skin conditions as well. The headquarters is in USA.
  9. Evotec SE

    World Rank (Jan-05-2024)
    3,987
    Market Cap (Jan-05-2024)
    3.387 Billion USD
    World Rank (Jul-30-2023)
    3,264
    Market Cap (Jul-30-2023)
    4.483 Billion USD
    World Rank (Dec-25-2022)
    4,226
    Market Cap (Dec-25-2022)
    2.868 Billion USD
    World Rank (Jan-07-2022)
    2,406
    Market Cap (Jan-07-2022)
    7.42 Billion USD
    Annual Revenue in USD
    828 Million USD
    Annual Operating Income in USD
    23 Million USD
    Annual Net Income in USD
    -193 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Evotec is a drug discovery alliance and development partnership company focused on innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups. Headquarters is in Germany.

    As on 2020, Evotec has 3,030 employees across 14 countries.

    Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, UCB.

  10. IPCA Laboratories

    World Rank (Jan-05-2024)
    3,990
    Market Cap (Jan-05-2024)
    3.385 Billion USD
    World Rank (Jul-30-2023)
    4,748
    Market Cap (Jul-30-2023)
    2.641 Billion USD
    World Rank (Dec-25-2022)
    7,124
    Market Cap (Dec-25-2022)
    1.320 Billion USD
    World Rank (Jan-07-2022)
    4,129
    Market Cap (Jan-07-2022)
    3.72 Billion USD
    Annual Revenue in USD
    722 Million USD
    Annual Net Income in USD
    111 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    IPCA Laboratories is a leading Fully Integrated Pharmaceutical company. It has been a crucial healthcare partner in over 120 countries across the 6 continents and manufactures over 350 formulations and 80 APIs for various therapeutic segments. The company annual revenue is 631.2 million USD and 14,066 employees as on 2020. The headquarters is in India.

Share

Ads